Hepatorenal Syndrome - 25 Studies Found

Active, not recruiting : Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
:
  • Cirrhosis
  • Hepatorenal Syndrome Type I

: 2012-02-09
: Drug: Terlipressin and albumin Terlipressin dose: 2mg/24h,
Recruiting : The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure
: Hepatorenal Syndrome
: 2015-07-01
: Drug: Terlipressin
Suspended : Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
:
  • Cirrhosis
  • Hepatorenal Syndrome

: 2006-02-03
: Drug: terlipressin
Recruiting : A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1
: Hepatorenal Syndrome
: 2016-05-10
:
  • Drug: Terlipressin acetate Lyo
Terminated : Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
:
  • Cirrhosis
  • Hepatorenal Syndrome

: 2008-08-26
:
  • Drug: Terlipressin plus albumin

Terminated : Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
:
  • Cirrhosis
  • Type 1 Hepatorenal Syndrome

: 2008-08-26
:
  • Drug: terlipressin given by intravenous boluses and albumin

Completed : Plasma and Hemodynamic Markers During Hepatectomy
: Hepatorenal Syndrome, Liver Regeneration
: 2012-10-02
: Procedure: Liver resection Liver resection of patient with neoplastic hepatic tumors
Terminated : Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
:
  • Hepatorenal Syndrome
  • Renal Failure
  • Procedure: Blood Draws and a hepatectomy specimen

Completed : TYPE 2 HEPATORENAL SYNDROME
: Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS
: 2012-06-28
:
  • Drug: Noradrenaline Patients i
Completed : A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
: HRS
: 2010-06-11
:
  • Drug: Terlipressin Blinded ter
<<< Previous | Next >>>